Please wait a minute...
文章检索
预防医学  2017, Vol. 29 Issue (8): 762-765    DOI: 10.19485/j.cnki.issn1007-0931.2017.08.002
  论著 本期目录 | 过刊浏览 | 高级检索 |
常见恶性肿瘤归因2型糖尿病风险及医疗经济负担研究
胡如英, 潘劲, 武海滨, 龚巍巍, 王蒙
浙江省疾病预防控制中心,浙江 杭州 310051
A study on the risk and economic burden of common malignant tumor due to type 2 diabetes mellitus
HU Ru-ying, PAN Jin, WU Hai-bin, GONG Wei-wei, WANG Meng
Zhejiang Provincial Center for Disease Control and Prevention,Hangzhou,Zhejiang,310051,China
全文: PDF(432 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 研究常见恶性肿瘤归因2型糖尿病的风险和直接医疗经济负担。方法 收集2007—2013年浙江省慢性病监测和随访数据库中糖尿病和恶性肿瘤发病资料及第五次卫生服务调查的医疗费用资料,分析2型糖尿病发生恶性肿瘤的人群归因危险度和恶性肿瘤直接医疗经济负担,进而估算2型糖尿病引起的恶性肿瘤直接医疗经济负担。结果 2型糖尿病患者发生恶性肿瘤归因危险度RR为1.68(95%CI:1.68~1.70);归因危险度百分比(AR%)为40.57%,以甲状腺癌最高(73.49%);人群归因危险度百分比(PAR%)为2.05%,以结肠癌最高(2.44%)。恶性肿瘤年均住院医疗费用110.99亿元,占当年卫生总费用的6.48%,其归因于2型糖尿病的直接医疗经济负担为2.28亿元。归因2型糖尿病的直接医疗经济负担前3位为肺癌、结肠癌和胃癌。结论 2型糖尿病增加恶性肿瘤发生风险,归因2型糖尿病的恶性肿瘤直接医疗经济负担达2.28亿元。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
胡如英
潘劲
武海滨
龚巍巍
王蒙
关键词 恶性肿瘤2型糖尿病人群归因危险度经济负担    
AbstractObjective To evaluate risk and the direct economic burden of malignant tumor due to type 2 diabetes mellitus. Methods Combing the data of chronic disease surveillance,follow-up and the fifth health service investigation,we calculated the population attributable risk and the direct economic burden for malignant tumor due to type 2 diabetes mellitus in order to estimate the direct economic burden for tumor caused by type 2 diabetes mellitus. Results The relative risk was 1.68 (95%CI: 1.68-1.70) for people with type 2 diabetes mellitus to develop the malignant tumor than the people without type 2 diabetes mellitus. The proportions of attributable risk (AR%) and population attributable risk (PAR%)were 40.57% and 2.05%,respectively. Moreover,the annual average hospitalization costs for malignant tumor reached 11 billion CNY,which took part 6.48% of total health service costs. And the direct economic burden for malignant tumor due to type 2 diabetes mellitus was 0.228 billion CNY. In addition,the top two highest population attributable risks were colorectal cancer and liver cancer,while the top three greatest direct economic burdens for malignant tumor or malignant tumor due to type 2 diabetes mellitus were lung cancer,colorectal cancer and stomach cancer. Conclusion From this study,we found that type 2 diabetes mellitus increased the risks of tumor and therefore lead to sharply increasing in medical costs of malignant tumor. In order to decrease the risk of malignant tumor and medical costs,we should pay more attention to the prevention of type 2 diabetes mellitus and the screening of malignant tumor due to type 2 diabetes mellitus.
Key wordsMalignant tumor    Type 2 diabetes    Population attributable risk    Economic burden
收稿日期: 2016-11-07      修回日期: 2017-02-03      出版日期: 2017-08-10
中图分类号:  R587.1  
基金资助:浙江省公益技术应用研究计划(2017C33090)
作者简介: 胡如英,本科,主任医师,主要从事慢性病防制工作
通信作者: 胡如英,E-mail:ryhu@cdc.zj.cn   
引用本文:   
胡如英, 潘劲, 武海滨, 龚巍巍, 王蒙. 常见恶性肿瘤归因2型糖尿病风险及医疗经济负担研究[J]. 预防医学, 2017, 29(8): 762-765.
HU Ru-ying, PAN Jin, WU Hai-bin, GONG Wei-wei, WANG Meng. A study on the risk and economic burden of common malignant tumor due to type 2 diabetes mellitus. Preventive Medicine, 2017, 29(8): 762-765.
链接本文:  
https://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn1007-0931.2017.08.002      或      https://www.zjyfyxzz.com/CN/Y2017/V29/I8/762
[1] YANG W Y,LU J M,WENG J P,et al. Prevalence of Diabetes among Men and Women in China[J]. New England Journal of Medicine,2010,362(25):1090-1101.
[2] BUTLE L M,WANG R,KOH W P,et al. Marine n-3 and saturated fatty acids in relation to risk of Colorectal cancer in Singapore Chinese:a prospective study[J]. Int J Cancer,2009,124(3):678-686.
[3] FRIBERG E,ORSINI N,MANTZOROS C S,et al. Diabetes mellitus and risk of endometnial cancer:a meta-analysis[J]. Diabetologia,2007,50(7):1365-1374
[4] NOVOSYADIYY R,LEROITH D. Hyperinsulinemia and type 2 diabetes[J]. Cellcycle,2010,9 (8):1449-50
[5] GIOVANNUCCI E,HARLAN D M,ARCHER M C,et al. Diabetes and cancer: a consensus report [J]. CA Cancer J Clin,2010,33(7)1674-1678.
[6] WANG C,WANG X,GONG G,et al. Increased risk of hepatocellular carcinoma in patients with diabetes mellitus:A systematic review and meta-analysis of cohort studies[J]. Int J Cancer,2011,130(7):1639-1648.
[7] BI Y,LU J,WANG W,et al. Cohort Profile:Risk evaluation of cancers in Chinese diabetic Individuals: a longitudinal (REACTION)study[J]. J Diabetes,2014,6(2):147-157.
[8] 胡如英,龚巍巍,王蒙,等. 2型糖尿病与恶性肿瘤发病风险关系的队列研究,中华流行病学杂志,2015,36(12):1384-13866
[9] 陈万青,郑荣寿,曾红梅,等. 1989-2008 年中国恶性肿瘤发病趋势分析[J]. 中华肿瘤杂志,2012,34 (7): 517-524.
[10] 费方荣,胡如英,钟节鸣,等. 浙江省20 1 4年恶性肿瘤发病死亡分析[J]. 中华流行病学杂志. 2016,37(5):694-698
[11] 中国疾病预防控制中心,中国疾病预防控制中心慢性非传染性疾病预防控制中心. 中国慢性病及其危险因素监测报告2013[M]. 北京:军事医学出版社,2016.
[12] 潘劲,胡如英,龚巍巍,等. 浙江省2007至2012年糖尿病流行特征的描述性分析析[J]. 中华内分泌杂志,2015,31(10):846-850
[13] 胡如英,俞敏,沈玉华,等. 中老年农村居民糖尿病现况调查[J]. 浙江预防医学,2014,26(10):973-766,985.
[14] KO C,CHAUDHRY S. The need for a multidisciplinary approach to cancer care[J]. J Surg Res,2002,105(1):53-57.
[15] 姜虹,王尚农. 2型糖尿病血糖及血脂变化情况对甲状腺癌发生的影响研究[J]. 中国实验诊断学,2014,18(11):1826-1828
[16] LO S F,CHANG S N,Muo C H,et al. Modest increase in risk of specific types of cancer types in type 2 diabetes mellitus patients[J]. Int J Cancer,2013,132(1):182-188
[17] 浙江省统计局,国家统计局浙江调查总队. 2013年浙江省国民经济和社会发展统计公报[J]. 统计科学与实践,2014,(3):4-10
[18] 浙江省卫生信息中心. 二○一四年浙江省卫生统计资料汇编[M]. 浙江省卫生和计划生育委员会,2014.
[19] 郑亚明,纪立农,吴晶. 中国糖尿病经济负担研究系统综述[J]. 中华内分泌代谢杂志,2012,28 (10):821-825.
[20] BEN Q,XU M,NING X,et al. Diabetes mellitus and risk of pancreatic cancer: a meta. analysis of cohort studies[J]. Eur J Cancer,2011,47(13):1928-1937.
[21] HERRY S A,PRIZMENT A E,ANDERSON K E. Duration of diabetes and pancreatic cancer in a case-control study in the midwest and the iowa women′s Health study (IWHS)cohort[J]. JOP,2013,14 (3):243-249.
[1] 吴成慧, 彭艳红, 张可, 朱维晔, 邓亮, 谭玲玲, 瞿丹丹, 米秋香. 中青年2型糖尿病患者益处发现的影响因素分析[J]. 预防医学, 2026, 38(1): 31-35.
[2] 陆杰, 张柯, 吴雅, 王玥, 张玥, 陆叶, 吴周理, 任志华, 黄艺文. 肥胖指标预测2型糖尿病患者心脑血管疾病的效果比较[J]. 预防医学, 2025, 37(9): 886-891.
[3] 张凯慧, 李婉玲, 王彦兴, 安愿. 老年2型糖尿病患者心理灵活性、运动自我效能在衰弱与社会疏离间的中介效应分析[J]. 预防医学, 2025, 37(8): 783-788.
[4] 刘明坤, 张丰香, 韩彩静, 王霞, 陈世坤, 金梅, 孙金月. 2型糖尿病患者周围神经病变风险预测模型研究[J]. 预防医学, 2025, 37(7): 692-696.
[5] 俞丹丹, 杨加丽, 张雅萍, 许慧琳, 何丹丹, 李俊. 2型糖尿病共病患者空腹血糖波动轨迹的影响因素研究[J]. 预防医学, 2025, 37(6): 562-567,572.
[6] 李美琳, 周梦姣, 吴佳芸, 喻喆, 孔利萍. 老年男性2型糖尿病患者合并肌少症的影响因素分析[J]. 预防医学, 2025, 37(6): 588-592.
[7] 陆丽君, 袁磊, 李殿江, 卢昆, 朱怡萱, 王志勇, 刘思浚. 老年2型糖尿病患者自我效能、自我管理行为在抑郁症状与血糖控制间的中介效应分析[J]. 预防医学, 2025, 37(5): 455-459.
[8] 蒋舒頔, 郭婷, 凌军军, 任婕, 张亮. 初次性行为年龄与妇科恶性肿瘤的孟德尔随机化研究[J]. 预防医学, 2025, 37(5): 516-520.
[9] 王英杰 综述, 孙高峰, 审校. 2型糖尿病预测模型研究进展[J]. 预防医学, 2025, 37(4): 369-372,377.
[10] 孙霞, 但玲英, 郑鹏, 陈薪伊. 2型糖尿病患者脂肪因子与糖尿病视网膜病变的关联研究[J]. 预防医学, 2025, 37(3): 248-252.
[11] 陈海苗, 马岩, 刘明奇, 马珊珊, 李军, 方益荣. 儿童期肥胖与2型糖尿病、冠心病的孟德尔随机化研究[J]. 预防医学, 2025, 37(3): 307-311.
[12] 赵琳, 蒋龙艳, 徐斌, 唐咸艳. 南宁市五种主要恶性肿瘤发病率分析[J]. 预防医学, 2025, 37(2): 135-138.
[13] 文进博, 张婷, 赵倩, 刘景, 孙中明, 侯建斌, 陆正权, 许雨婷, 马新雄, 潘恩春. 2型糖尿病患者运动处方干预效果评价[J]. 预防医学, 2025, 37(12): 1211-1216.
[14] 杜灵彬, 邱雨, 李辉章, 李润华, 朱陈, 王乐, 裘燕飞. 2021年浙江省肿瘤登记地区恶性肿瘤发病和死亡特征分析[J]. 预防医学, 2025, 37(10): 973-978.
[15] 韩仁强, 缪伟刚, 俞浩, 陶然, 周金意. 2009—2021年江苏省肿瘤登记地区恶性肿瘤发病趋势及年龄变化分析[J]. 预防医学, 2025, 37(10): 979-984,990.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed